Use of K-252a and kinase inhibitors for the prevention or treatment of HMGB1-associated pathologies

Details for Australian Patent Application No. 2005266447 (hide)

International Classifications

Event Publications

1 February 2007 PCT application entered the National Phase

PCT publication WO2006/010628 Priority application(s): WO2006/010628

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.